Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
BellBrook
Veliparib (PARP1 & PARP2 Inhibitor)
As low as
535
CHF
CHF 535.00
In stock
Only %1 left
BBL-5004-M02525 mgCHF 535.00
NEW

Product Details | |
---|---|
Synonyms | ABT-888; 2-[(2R)-2-Methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide dihydrochloride |
Product Type | Chemical |
Properties | |
Formula |
C12H16N4O . 2HCl |
MW | 317.2 |
CAS | 912445-05-7 |
Purity Chemicals | ≥98% (TLC) |
Appearance | White solid. |
Solubility | Soluble in DMSO (30mg/ml) or water (40mg/ml) |
Identity | Determined by 1H-NMR. |
InChi Key | DSBSVDCHFMEYBX-FFXKMJQXSA-N |
Smiles | NC(C1=CC=CC2=C1N=C([C@@]3(NCCC3)C)N2)=O.Cl.Cl |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Use/Stability |
Stable for at least 1 year after receipt when stored at +4°C. Stock solutions are stable for at least 3 months when stored at -20°C. |
Documents | |
Product Specification Sheet | |
Datasheet |
![]() |
Description
Veliparib 2HCl is a PARP1 and PARP2 inhibitor that has been fully validated using the Transcreener pADPr PARP Assay and Enzolution Assay Systems. An IC50 of 1.42 nM for PARP1 and an IC50 of 1.5 nM for PARP2 were obtained using a 12-point dose-response assay.
Described to be an inhibitor of PARP1 and PARP2 (Kis = 5.2 and 2.9 nM, respectively). Restores sensitivity to DNA alkylator/methylator temozolomide in glioma cells and xenografts and enhances radiotherapy sensitivity in endometrial carcinoma cells. Also improves sensitivity to DNA replication inhibitor cisplatin in human oral carcinoma cells.